An example of the precision afforded by Misonix ultrasound cutting technologies: an eggshell is cut and the membrane is left intact. In an agreement finalized Tuesday, Aesculap announced it will distribute the […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of China approved BioSphere’s Embosphere Microspheres for clinical […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms. The study examined 366,475 […]
AngioDynamics Technology Not Responsible for Lung Tumor Treatment Deaths
In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. Concerns were raised about the safety and adverse event reporting associated with […]
AngioDynamics’ RFA Shows Promise for Patients with Unresectable Liver Metastases
A recent study conducted by Dr. Allan Siperstein and colleagues at the Cleveland Clinic presented three and five year survival data following radiofrequency ablation of colorectal liver metastases. As Siperstein noted in […]
Minneapolis Firm Raises $11.8M for Lymphedema System
Tactile Systems Technology, a Minneapolis, MN, company whose technology treats vascular disorders such as lymphedema, has raised $11.8 million. The financing, led by Galen Partners of Stamford, CT, will be used to […]
New Cervical-Cancer Test Cleared in Europe
Diamics, a Novato, CA, diagnostics company, has received CE Mark approval for a molecular-based cervical cancer-screening tool designed to improve the effectiveness of traditional testing methods. The Pap-Map System — which uses […]
Investors Commit $30M to Rare-Cell Detection Tests
Ikonisys, a New Haven, CT, company that makes cell-based diagnostics for women’s health and oncology, has closed $30 million in Series E funding. The financing follows FDA clearance of two diagnostic applications […]
